Skip to Main Content

Paper Details

The future of patient-derived xenografts in prostate cancer research.
Nat Rev Urol
2
2023
PDXs, Patient, human, human tumours, mice, patient, prostate cancer, tumour, tumours
Author NameAffiliation
Mitchell G LawrenceMonash University
Mitchell G LawrenceMonash Biomedicine Discovery Institute
Mitchell G LawrencePeter MacCallum Cancer Centre
Mitchell G LawrenceThe University of Melbourne
Mitchell G LawrenceCabrini Institute
Renea A TaylorMonash Biomedicine Discovery Institute
Renea A TaylorPeter MacCallum Cancer Centre
Renea A TaylorThe University of Melbourne
Renea A TaylorCabrini Institute
Renea A TaylorMonash University
Nora M NavoneThe University of Texas MD Anderson Cancer Center
Nora M NavoneDavid H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center
Yuzhuo Wang
Yuzhuo WangUniversity of British Columbia
Yuzhuo Wang
Eva CoreyUniversity of Washington
Peter S NelsonDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Gail P RisbridgerMonash University
Gail P RisbridgerMonash Biomedicine Discovery Institute
Gail P RisbridgerPeter MacCallum Cancer Centre
Gail P RisbridgerThe University of Melbourne
Gail P RisbridgerCabrini Institute
  • 1 - 25

Datasets

Release 1.2